Table 1.
Type and use of ultrasound contrast agents
| SLN identification | SLN characterization |
||
|---|---|---|---|
| Sonazoid | Dual-targeted | Control | |
| Manufacturer | GE Healthcare, Oslo, Norway | Targeson, San Diego, CA, USA | Targeson, San Diego, CA, USA |
| Diameter | 1–6 μm | 2–8 μm | 2–8 μm |
| Composition | Lipid stabilized suspension of perfluorobutane | Streptavidin coated bubble filled with perfluorocarbon (labeled with P-selectin and αvβ3-integrin antibodies) | Streptavidin coated bubble filled with perfluorocarbon (labeled with immunoglobulin G) |
| Administration | Peritumoral injection | IV | IV |
| Dose | 0.25 ml × 4 | 1.25 ml | 1.25 ml |